Metabolic Steal of the Myocardium by Primary Cardiac Lymphoma

Less than 1.0% of malignant lymphomas are primary cardiac lymphoma (PCL), a rare malignant lymphoma. Due to its infrequency, the metabolic dynamics of the treatment have not been completely analyzed. A 62-year-old man who had been complaining of exertional dyspnea for a month arrived at our emergenc...

Full description

Bibliographic Details
Main Authors: Osamu Imataki, Hiroyuki Kubo, Haruyuki Fujita, Makiko Uemura
Format: Article
Language:English
Published: Karger Publishers 2023-01-01
Series:Case Reports in Oncology
Subjects:
Online Access:https://www.karger.com/Article/FullText/527638
_version_ 1811168096324419584
author Osamu Imataki
Hiroyuki Kubo
Haruyuki Fujita
Makiko Uemura
author_facet Osamu Imataki
Hiroyuki Kubo
Haruyuki Fujita
Makiko Uemura
author_sort Osamu Imataki
collection DOAJ
description Less than 1.0% of malignant lymphomas are primary cardiac lymphoma (PCL), a rare malignant lymphoma. Due to its infrequency, the metabolic dynamics of the treatment have not been completely analyzed. A 62-year-old man who had been complaining of exertional dyspnea for a month arrived at our emergency room. He developed right cardiac failure as a result of a mass in the right atrium, according to a computed tomography (CT) scan. According to an echocardiogram, the mass was obstructing his blood flow and affecting how his heart worked. The lump was pathologically determined to be diffuse large B-cell lymphoma after he underwent urgent heart surgery. The lesion was only localized in the heart, according to a postoperative 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET)/CT scan, indicating that the disease was in clinical stage IE. An 18F-FDG-PET/CT scan showed a thickness of the right atrial wall as residual disease despite the majority of the cardiac lymphomatous mass being removed during surgery; it also showed that the usual uptake of 18F-FDG in healthy myocardium had diminished. Following chemotherapy, 18F-FDG uptake recovered in the patient’s normal myocardium of the heart in remission. In conclusion, a sort of “metabolic steal phenomenon” that may be connected to PCL is the difference in uptake between tumor-involved and healthy myocardium.
first_indexed 2024-04-10T16:20:18Z
format Article
id doaj.art-75e6faf5e25a40e292d1e6a0cbb227f1
institution Directory Open Access Journal
issn 1662-6575
language English
last_indexed 2024-04-10T16:20:18Z
publishDate 2023-01-01
publisher Karger Publishers
record_format Article
series Case Reports in Oncology
spelling doaj.art-75e6faf5e25a40e292d1e6a0cbb227f12023-02-09T15:14:03ZengKarger PublishersCase Reports in Oncology1662-65752023-01-0116171210.1159/000527638527638Metabolic Steal of the Myocardium by Primary Cardiac LymphomaOsamu Imataki0https://orcid.org/0000-0001-5332-1316Hiroyuki Kubo1Haruyuki Fujita2Makiko Uemura3Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Takamatsu, JapanDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Takamatsu, JapanDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Takamatsu, JapanDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Takamatsu, JapanLess than 1.0% of malignant lymphomas are primary cardiac lymphoma (PCL), a rare malignant lymphoma. Due to its infrequency, the metabolic dynamics of the treatment have not been completely analyzed. A 62-year-old man who had been complaining of exertional dyspnea for a month arrived at our emergency room. He developed right cardiac failure as a result of a mass in the right atrium, according to a computed tomography (CT) scan. According to an echocardiogram, the mass was obstructing his blood flow and affecting how his heart worked. The lump was pathologically determined to be diffuse large B-cell lymphoma after he underwent urgent heart surgery. The lesion was only localized in the heart, according to a postoperative 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET)/CT scan, indicating that the disease was in clinical stage IE. An 18F-FDG-PET/CT scan showed a thickness of the right atrial wall as residual disease despite the majority of the cardiac lymphomatous mass being removed during surgery; it also showed that the usual uptake of 18F-FDG in healthy myocardium had diminished. Following chemotherapy, 18F-FDG uptake recovered in the patient’s normal myocardium of the heart in remission. In conclusion, a sort of “metabolic steal phenomenon” that may be connected to PCL is the difference in uptake between tumor-involved and healthy myocardium.https://www.karger.com/Article/FullText/527638primary cardiac lymphomametabolic steal phenomenonpositron emission tomography18f-fluorodeoxyglucose
spellingShingle Osamu Imataki
Hiroyuki Kubo
Haruyuki Fujita
Makiko Uemura
Metabolic Steal of the Myocardium by Primary Cardiac Lymphoma
Case Reports in Oncology
primary cardiac lymphoma
metabolic steal phenomenon
positron emission tomography
18f-fluorodeoxyglucose
title Metabolic Steal of the Myocardium by Primary Cardiac Lymphoma
title_full Metabolic Steal of the Myocardium by Primary Cardiac Lymphoma
title_fullStr Metabolic Steal of the Myocardium by Primary Cardiac Lymphoma
title_full_unstemmed Metabolic Steal of the Myocardium by Primary Cardiac Lymphoma
title_short Metabolic Steal of the Myocardium by Primary Cardiac Lymphoma
title_sort metabolic steal of the myocardium by primary cardiac lymphoma
topic primary cardiac lymphoma
metabolic steal phenomenon
positron emission tomography
18f-fluorodeoxyglucose
url https://www.karger.com/Article/FullText/527638
work_keys_str_mv AT osamuimataki metabolicstealofthemyocardiumbyprimarycardiaclymphoma
AT hiroyukikubo metabolicstealofthemyocardiumbyprimarycardiaclymphoma
AT haruyukifujita metabolicstealofthemyocardiumbyprimarycardiaclymphoma
AT makikouemura metabolicstealofthemyocardiumbyprimarycardiaclymphoma